Close Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.58M Sell
4,086
-582
-12% -$216K 0.04% 73
2026
Q1
$1.37M Sell
4,668
-1,673
-26% -$550K 0.04% 75
2025
Q4
$2.22M Sell
6,341
-482
-7% -$163K 0.05% 71
2025
Q3
$2.21M Sell
6,823
-368,370
-98% -$115M 0.05% 70
2025
Q2
$146M Buy
375,193
+190
+0.1% +$76.4K 4.27% 6
2025
Q1
$163M Buy
375,003
+1,456
+0.4% +$584K 4.69% 5
2024
Q4
$138M Hold
373,547
3.88% 10
2024
Q3
$194M Buy
373,547
+4,214
+1% +$2.25M 5.97% 4
2024
Q2
$200M Buy
369,333
+77,571
+27% +$41M 6.8% 3
2024
Q1
$151M Buy
+291,762
New +$145M 5.52% 4

Other funds holding ELV

Close Asset Management's ELV Position: Q2 2026 in Review

Close Asset Management reduced its Elevance Health (ELV) stake by 12% in Q2 2026, selling an estimated $216K and leaving 4,086 shares worth $1.58M. The position accounts for 0.04% of the portfolio, ranked #73.

Close Asset Management first reported a position in ELV in Q1 2024 and has held it in 10 quarters since. The position peaked at $200M in Q2 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Close Asset Management held 4,086 shares of Elevance Health worth $1.58M as of Q2 2026.
  • Close Asset Management sold 582 Elevance Health shares in Q2 2026, an estimated $216K.
  • Elevance Health made up 0.04% of Close Asset Management's portfolio in Q2 2026, its #73 holding.
  • Close Asset Management first reported a position in Elevance Health in Q1 2024 and has held it in 10 quarters since.
  • Close Asset Management's Elevance Health position peaked at $200M in Q2 2024.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Close Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.